Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Longeveron Has Been Granted Australian Patent Number 2017213812 Titled "Mesenchymal Stem Cells As Vaccine Adjuvants And Methods For Using The Same".

Author: Benzinga Newsdesk | August 01, 2024 12:51pm

https://ipsearch.ipaustralia.gov.au/patents/2017213812

Posted In: LGVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist